4.9: Key Takeaways

Vaccine Practice for Health Professionals · LibreTexts

0%

Contents

    Text

    Size
    100%
    Theme
    Typeface
    Line length
    Spacing

    Read aloud

    How

    Speed: 1×
    Light up
    Highlight

    Symbols: Mulberry Symbols, © 2018–2026 Steve Lee, CC BY-SA 4.0 (licence, the set), the site's own copies.

    From LibreTexts, under CC BY-SA 4.0, as the source states it; its equations are written in TeX, which the PDF shows typeset. This page at LibreTexts.

    4.9: Key Takeaways

    The key takeaways of this chapter are:

    • Vaccine safety is a highly regulated, scrutinous process in Canada.
    • Vaccines undergo various stages of research before receiving license issuance by Health Canada.
    • Vaccine evaluation is ongoing, even after licensure. Post-marketing surveillance is important to ensure vaccines continue to be safe and to detect rare or serious adverse events.
    • Health professionals are required by law to report adverse events following immunization.
    • Adverse events following immunization should be reported when the event is serious or unexpected, and there is no other clear cause for the event. A causal relationship is not required to report the adverse event.

    This page titled 4.9: Key Takeaways was last modified on Fri, 03 Feb 2023 03:45:39 GMT and is shared under a CC BY-SA 4.0 license and was authored, remixed, and/or curated by Oona St-Amant, Jennifer Lapum, Vinita Dubey, Karen Beckermann, Che-Sheu Huang, Carly Weeks, Kate Leslie, and Kim English (eCampus Ontario) via source content that was edited to the style and standards of the LibreTexts platform.